Royce & Associates’s CryoPort CYRX Stock Holding History

Royce & Associates’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,198	Closed	-$590K	–	920
2023 Q2	$590K	Hold	34,198	–	–	0.01%	818
2023 Q1	$821K	Sell	34,198 -14,000	-29%	-$304K	0.01%	794
2022 Q4	$836K	Hold	48,198	–	–	0.01%	780
2022 Q3	$1.17M	Hold	48,198	–	–	0.01%	707
2022 Q2	$1.49M	Hold	48,198	–	–	0.02%	696
2022 Q1	$1.68M	Buy	48,198 +14,000	+41%	+$529K	0.01%	742
2021 Q4	$2.02M	Hold	34,198	–	–	0.02%	726
2021 Q3	$2.27M	Buy	34,198 +11,000	+47%	+$678K	0.02%	726
2021 Q2	$1.46M	Hold	23,198	–	–	0.01%	803
2021 Q1	$1.21M	Sell	23,198 -114,817	-83%	-$6.98M	0.01%	829
2020 Q4	$6.06M	Buy	138,015 +21,117	+18%	+$1.01M	0.05%	511
2020 Q3	$5.54M	Sell	116,898 -114,900	-50%	-$4.65M	0.06%	445
2020 Q2	$7.01M	Buy	231,798 +9,600	+4%	+$214K	0.08%	375
2020 Q1	$3.79M	Sell	222,198 -68,000	-23%	-$1.19M	0.05%	453
2019 Q4	$4.78M	Buy	290,198 +25,000	+9%	+$372K	0.04%	499
2019 Q3	$4.34M	Buy	265,198 +25,000	+10%	+$501K	0.04%	509
2019 Q2	$4.4M	Hold	240,198	–	–	0.04%	523
2019 Q1	$3.1M	Hold	240,198	–	–	0.03%	617
2018 Q4	$2.65M	Buy	240,198 +15,000	+7%	+$163K	0.02%	649
2018 Q3	$2.88M	Sell	225,198 -36,000	-14%	-$514K	0.02%	739
2018 Q2	$4.12M	Hold	261,198	–	–	0.03%	646
2018 Q1	$2.25M	Buy	261,198 +41,000	+19%	+$362K	0.02%	819
2017 Q4	$1.89M	Buy	220,198 +82,998	+60%	+$651K	0.01%	862
2017 Q3	$1.35M	Buy	+137,200	New	+$1.01M	0.01%	899

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Royce & Associates's CYRX Position: Q3 2023 in Review

Royce & Associates sold out of CryoPort (CYRX) in Q3 2023, closing a stake of 34,198 shares — an estimated $590K sold.

Royce & Associates first reported a position in CYRX in Q3 2017 and held it in 24 quarters. The position peaked at $7.01M in Q2 2020. 159 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

Royce & Associates reported no remaining CryoPort position as of Q3 2023 after selling out during the quarter.
Royce & Associates sold 34,198 CryoPort shares in Q3 2023, an estimated $590K.
Royce & Associates first reported a position in CryoPort in Q3 2017 and held it in 24 quarters.
Royce & Associates's CryoPort position peaked at $7.01M in Q2 2020.
159 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Royce & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.